共 7 条
[1]
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
[J].
Bellmunt, J.
;
de Wit, R.
;
Vaughn, D. J.
;
Fradet, Y.
;
Lee, J. -L.
;
Fong, L.
;
Vogelzang, N. J.
;
Climent, M. A.
;
Petrylak, D. P.
;
Choueiri, T. K.
;
Necchi, A.
;
Gerritsen, W.
;
Gurney, H.
;
Quinn, D. I.
;
Culine, S.
;
Sternberg, C. N.
;
Mai, Y.
;
Poehlein, C. H.
;
Perini, R. F.
;
Bajorin, D. F.
.
NEW ENGLAND JOURNAL OF MEDICINE,
2017, 376 (11)
:1015-1026

论文数: 引用数:
h-index:
机构:

de Wit, R.
论文数: 0 引用数: 0
h-index: 0
机构:
Erasmus MC Canc Inst, Rotterdam, Netherlands Dana Farber Canc Inst, 450 Brookline Ave,Dana Bldg 1230, Boston, MA 02215 USA

Vaughn, D. J.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA Dana Farber Canc Inst, 450 Brookline Ave,Dana Bldg 1230, Boston, MA 02215 USA

Fradet, Y.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Laval, Ctr Hosp Univ Quebec, Quebec City, PQ, Canada Dana Farber Canc Inst, 450 Brookline Ave,Dana Bldg 1230, Boston, MA 02215 USA

Lee, J. -L.
论文数: 0 引用数: 0
h-index: 0
机构:
Asan Med Ctr, Seoul, South Korea
Univ Ulsan, Coll Med, Seoul, South Korea Dana Farber Canc Inst, 450 Brookline Ave,Dana Bldg 1230, Boston, MA 02215 USA

Fong, L.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Calif San Francisco, San Francisco, CA 94143 USA Dana Farber Canc Inst, 450 Brookline Ave,Dana Bldg 1230, Boston, MA 02215 USA

Vogelzang, N. J.
论文数: 0 引用数: 0
h-index: 0
机构:
Comprehens Canc Ctr Nevada, Las Vegas, NV USA Dana Farber Canc Inst, 450 Brookline Ave,Dana Bldg 1230, Boston, MA 02215 USA

Climent, M. A.
论文数: 0 引用数: 0
h-index: 0
机构:
Fdn Inst Valenciano Oncol, Valencia, Spain Dana Farber Canc Inst, 450 Brookline Ave,Dana Bldg 1230, Boston, MA 02215 USA

Petrylak, D. P.
论文数: 0 引用数: 0
h-index: 0
机构:
Yale Univ, Smilow Canc Hosp, New Haven, CT USA Dana Farber Canc Inst, 450 Brookline Ave,Dana Bldg 1230, Boston, MA 02215 USA

Choueiri, T. K.
论文数: 0 引用数: 0
h-index: 0
机构:
Dana Farber Canc Inst, 450 Brookline Ave,Dana Bldg 1230, Boston, MA 02215 USA Dana Farber Canc Inst, 450 Brookline Ave,Dana Bldg 1230, Boston, MA 02215 USA

Necchi, A.
论文数: 0 引用数: 0
h-index: 0
机构:
Fdn IRCCS Ist Nazl Tumori, Milan, Italy Dana Farber Canc Inst, 450 Brookline Ave,Dana Bldg 1230, Boston, MA 02215 USA

Gerritsen, W.
论文数: 0 引用数: 0
h-index: 0
机构:
Radboud Univ Nijmegen, Med Ctr, Nijmegen, Netherlands Dana Farber Canc Inst, 450 Brookline Ave,Dana Bldg 1230, Boston, MA 02215 USA

论文数: 引用数:
h-index:
机构:

Quinn, D. I.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Southern Calif, Norris Comprehens Canc Ctr & Hosp, Los Angeles, CA USA Dana Farber Canc Inst, 450 Brookline Ave,Dana Bldg 1230, Boston, MA 02215 USA

Culine, S.
论文数: 0 引用数: 0
h-index: 0
机构:
Hop St Louis, Paris, France Dana Farber Canc Inst, 450 Brookline Ave,Dana Bldg 1230, Boston, MA 02215 USA

Sternberg, C. N.
论文数: 0 引用数: 0
h-index: 0
机构:
San Camillo Hosp, Rome, Italy
Forlanini Hosp, Rome, Italy Dana Farber Canc Inst, 450 Brookline Ave,Dana Bldg 1230, Boston, MA 02215 USA

Mai, Y.
论文数: 0 引用数: 0
h-index: 0
机构:
Merck, Kenilworth, NJ USA Dana Farber Canc Inst, 450 Brookline Ave,Dana Bldg 1230, Boston, MA 02215 USA

Poehlein, C. H.
论文数: 0 引用数: 0
h-index: 0
机构:
Merck, Kenilworth, NJ USA Dana Farber Canc Inst, 450 Brookline Ave,Dana Bldg 1230, Boston, MA 02215 USA

Perini, R. F.
论文数: 0 引用数: 0
h-index: 0
机构:
Merck, Kenilworth, NJ USA Dana Farber Canc Inst, 450 Brookline Ave,Dana Bldg 1230, Boston, MA 02215 USA

Bajorin, D. F.
论文数: 0 引用数: 0
h-index: 0
机构:
Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA Dana Farber Canc Inst, 450 Brookline Ave,Dana Bldg 1230, Boston, MA 02215 USA
[2]
Grosnon C, 2025, Bull Cancer
[3]
New approval: Avelumab - maintenance therapy for advanced or metastatic urothelial carcinoma
[J].
Le Brun, Iona Campo
;
Benderra, Marc-Antoine
.
BULLETIN DU CANCER,
2021, 108 (09)
:784-786

Le Brun, Iona Campo
论文数: 0 引用数: 0
h-index: 0
机构:
Hop Univ Henri Mondor, Grp Hospitalier Henri Mondor, 1 Rue Gustave Eiffel, F-94000 Creteil, France Hop Univ Henri Mondor, Grp Hospitalier Henri Mondor, 1 Rue Gustave Eiffel, F-94000 Creteil, France

Benderra, Marc-Antoine
论文数: 0 引用数: 0
h-index: 0
机构:
Hop Tenon Oncol Med, 4 Rue Chine, F-75020 Paris, France Hop Univ Henri Mondor, Grp Hospitalier Henri Mondor, 1 Rue Gustave Eiffel, F-94000 Creteil, France
[4]
Drug approval: Enfortumab vedotin-advanced urothelial carcinoma (which have previously received platinum-containing chemotherapy and immunotherapy)
[J].
Matte, Paul
;
Campedel, Luca
.
BULLETIN DU CANCER,
2022, 109 (7-8)
:738-740

Matte, Paul
论文数: 0 引用数: 0
h-index: 0
机构:
Hop La Pitie Salpetriere, Serv Oncol Med, 47-83 Blvd Hop, F-75013 Paris, France Hop La Pitie Salpetriere, Serv Oncol Med, 47-83 Blvd Hop, F-75013 Paris, France

Campedel, Luca
论文数: 0 引用数: 0
h-index: 0
机构:
Hop La Pitie Salpetriere, Serv Oncol Med, 47-83 Blvd Hop, F-75013 Paris, France Hop La Pitie Salpetriere, Serv Oncol Med, 47-83 Blvd Hop, F-75013 Paris, France
[5]
Sex differences in muscle-invasive bladder cancers: A study of a French regional population
[J].
Poli, Charlotte
;
Tretarre, Brigitte
;
Trouche-Sabatier, Stephanie
;
Foucan, Anne-Sophie
;
Abdo, Nicolas
;
Poinas, Gregoire
;
Azria, David
;
Rebillard, Xavier
;
Iborra, Francois
.
FRENCH JOURNAL OF UROLOGY,
2025, 35 (01)

Poli, Charlotte
论文数: 0 引用数: 0
h-index: 0
机构:
Caremeau Univ Hosp, Dept Urol, 4 Rue Prof Robert Debre, F-30900 Nimes, France Caremeau Univ Hosp, Dept Urol, 4 Rue Prof Robert Debre, F-30900 Nimes, France

Tretarre, Brigitte
论文数: 0 引用数: 0
h-index: 0
机构:
Herault Canc Registry, Montpellier, France
Ctr Epidemiol & Res Populat Hlth CERPOP, Toulouse, France Caremeau Univ Hosp, Dept Urol, 4 Rue Prof Robert Debre, F-30900 Nimes, France

Trouche-Sabatier, Stephanie
论文数: 0 引用数: 0
h-index: 0
机构:
Herault Canc Registry, Montpellier, France Caremeau Univ Hosp, Dept Urol, 4 Rue Prof Robert Debre, F-30900 Nimes, France

Foucan, Anne-Sophie
论文数: 0 引用数: 0
h-index: 0
机构:
Herault Canc Registry, Montpellier, France Caremeau Univ Hosp, Dept Urol, 4 Rue Prof Robert Debre, F-30900 Nimes, France

Abdo, Nicolas
论文数: 0 引用数: 0
h-index: 0
机构:
Lapeyronie Univ Hosp, Dept Urol, Montpellier, France Caremeau Univ Hosp, Dept Urol, 4 Rue Prof Robert Debre, F-30900 Nimes, France

Poinas, Gregoire
论文数: 0 引用数: 0
h-index: 0
机构:
Clin Beau Soleil, Dept Urol, Montpellier, France Caremeau Univ Hosp, Dept Urol, 4 Rue Prof Robert Debre, F-30900 Nimes, France

Azria, David
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Montpellier, Natl Inst Hlth & Med Res, Inst Canc, U1194, Montpellier, France Caremeau Univ Hosp, Dept Urol, 4 Rue Prof Robert Debre, F-30900 Nimes, France

Rebillard, Xavier
论文数: 0 引用数: 0
h-index: 0
机构:
Clin Beau Soleil, Dept Urol, Montpellier, France Caremeau Univ Hosp, Dept Urol, 4 Rue Prof Robert Debre, F-30900 Nimes, France

Iborra, Francois
论文数: 0 引用数: 0
h-index: 0
机构:
Herault Canc Registry, Montpellier, France
Lapeyronie Univ Hosp, Dept Urol, Montpellier, France Caremeau Univ Hosp, Dept Urol, 4 Rue Prof Robert Debre, F-30900 Nimes, France
[6]
Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer
[J].
Powles, T.
;
Valderrama, B. P.
;
Gupta, S.
;
Bedke, J.
;
Kikuchi, E.
;
Hoffman-Censits, J.
;
Iyer, G.
;
Vulsteke, C.
;
Park, S. H.
;
Shin, S. J.
;
Castellano, D.
;
Fornarini, G.
;
Li, J. R.
;
Guemues, M.
;
Mar, N.
;
Loriot, Y.
;
Flechon, A.
;
Duran, I
;
Drakaki, A.
;
Narayanan, S.
;
Yu, X.
;
Gorla, S.
;
Moreno, B. Homet
;
van der Heijden, M. S.
.
NEW ENGLAND JOURNAL OF MEDICINE,
2024, 390 (10)
:875-888

Powles, T.
论文数: 0 引用数: 0
h-index: 0
机构:
Queen Mary Univ London, Barts Canc Inst Biomed Res Ctr, London, England Queen Mary Univ London, Barts Canc Inst Biomed Res Ctr, London, England

Valderrama, B. P.
论文数: 0 引用数: 0
h-index: 0
机构:
Hosp Univ Virgen del Rocio, Seville, Spain Queen Mary Univ London, Barts Canc Inst Biomed Res Ctr, London, England

Gupta, S.
论文数: 0 引用数: 0
h-index: 0
机构:
Cleveland Clin Fdn, Taussig Canc Inst, Cleveland, OH USA Queen Mary Univ London, Barts Canc Inst Biomed Res Ctr, London, England

Bedke, J.
论文数: 0 引用数: 0
h-index: 0
机构:
Katharinen Hosp, Klinikum Stuttgart, Stuttgart, Germany Queen Mary Univ London, Barts Canc Inst Biomed Res Ctr, London, England

Kikuchi, E.
论文数: 0 引用数: 0
h-index: 0
机构:
St Marianna Univ, Sch Med, Kawasaki, Japan Queen Mary Univ London, Barts Canc Inst Biomed Res Ctr, London, England

Hoffman-Censits, J.
论文数: 0 引用数: 0
h-index: 0
机构:
Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD USA Queen Mary Univ London, Barts Canc Inst Biomed Res Ctr, London, England

Iyer, G.
论文数: 0 引用数: 0
h-index: 0
机构:
Mem Sloan Kettering Canc Ctr, New York, NY USA Queen Mary Univ London, Barts Canc Inst Biomed Res Ctr, London, England

论文数: 引用数:
h-index:
机构:

Park, S. H.
论文数: 0 引用数: 0
h-index: 0
机构:
Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Seoul, South Korea Queen Mary Univ London, Barts Canc Inst Biomed Res Ctr, London, England

Shin, S. J.
论文数: 0 引用数: 0
h-index: 0
机构:
Yonsei Univ Hlth Syst, Severance Hosp, Seoul, South Korea Queen Mary Univ London, Barts Canc Inst Biomed Res Ctr, London, England

Castellano, D.
论文数: 0 引用数: 0
h-index: 0
机构:
Hosp Univ 12 Octubre, Madrid, Spain Queen Mary Univ London, Barts Canc Inst Biomed Res Ctr, London, England

Fornarini, G.
论文数: 0 引用数: 0
h-index: 0
机构:
Osped Policlin San Martino, Sci Inst Res Hospitalizat & Healthcare, Genoa, Italy Queen Mary Univ London, Barts Canc Inst Biomed Res Ctr, London, England

Li, J. R.
论文数: 0 引用数: 0
h-index: 0
机构:
Taichung Vet Gen Hosp, Taichung, Taiwan Queen Mary Univ London, Barts Canc Inst Biomed Res Ctr, London, England

Guemues, M.
论文数: 0 引用数: 0
h-index: 0
机构:
Istanbul Medeniyet Univ, Goztepe Training & Res Hosp, Istanbul, Turkiye Queen Mary Univ London, Barts Canc Inst Biomed Res Ctr, London, England

Mar, N.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Calif Irvine, Irvine Med Ctr, Orange, CA USA Queen Mary Univ London, Barts Canc Inst Biomed Res Ctr, London, England

Loriot, Y.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Paris Saclay, Inst Gustave Roussy, Villejuif, France Queen Mary Univ London, Barts Canc Inst Biomed Res Ctr, London, England

Flechon, A.
论文数: 0 引用数: 0
h-index: 0
机构:
Ctr Leon Berard, Lyon, France Queen Mary Univ London, Barts Canc Inst Biomed Res Ctr, London, England

Duran, I
论文数: 0 引用数: 0
h-index: 0
机构:
Hosp Univ Marques Valdecilla, Inst Invest Sanitaria Valdecilla, Santander, Spain Queen Mary Univ London, Barts Canc Inst Biomed Res Ctr, London, England

Drakaki, A.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Calif Los Angeles, Los Angeles Med Ctr, Los Angeles, CA USA Queen Mary Univ London, Barts Canc Inst Biomed Res Ctr, London, England

Narayanan, S.
论文数: 0 引用数: 0
h-index: 0
机构:
Seagen, Bothell, WA USA Queen Mary Univ London, Barts Canc Inst Biomed Res Ctr, London, England

Yu, X.
论文数: 0 引用数: 0
h-index: 0
机构:
Seagen, Bothell, WA USA Queen Mary Univ London, Barts Canc Inst Biomed Res Ctr, London, England

Gorla, S.
论文数: 0 引用数: 0
h-index: 0
机构:
Astellas Pharm US, Northbrook, IL USA Queen Mary Univ London, Barts Canc Inst Biomed Res Ctr, London, England

Moreno, B. Homet
论文数: 0 引用数: 0
h-index: 0
机构:
Merck, Rahway, NJ USA Queen Mary Univ London, Barts Canc Inst Biomed Res Ctr, London, England

van der Heijden, M. S.
论文数: 0 引用数: 0
h-index: 0
机构:
Netherlands Canc Inst, Amsterdam, Netherlands Queen Mary Univ London, Barts Canc Inst Biomed Res Ctr, London, England
[7]
Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma
[J].
Powles, Thomas
;
Rosenberg, Jonathan E.
;
Sonpavde, Guru P.
;
Loriot, Yohann
;
Duran, Ignacio
;
Lee, Jae-Lyun
;
Matsubara, Nobuaki
;
Vulsteke, Christof
;
Castellano, Daniel
;
Wu, Chunzhang
;
Campbell, Mary
;
Matsangou, Maria
;
Petrylak, Daniel P.
.
NEW ENGLAND JOURNAL OF MEDICINE,
2021, 384 (12)
:1125-1135

Powles, Thomas
论文数: 0 引用数: 0
h-index: 0
机构:
Queen Mary Univ London, Barts Canc Ctr, London, England Queen Mary Univ London, Barts Canc Ctr, London, England

Rosenberg, Jonathan E.
论文数: 0 引用数: 0
h-index: 0
机构:
Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA Queen Mary Univ London, Barts Canc Ctr, London, England

Sonpavde, Guru P.
论文数: 0 引用数: 0
h-index: 0
机构:
Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA Queen Mary Univ London, Barts Canc Ctr, London, England

Loriot, Yohann
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Paris Saclay, Gustave Roussy, Villejuif, France Queen Mary Univ London, Barts Canc Ctr, London, England

Duran, Ignacio
论文数: 0 引用数: 0
h-index: 0
机构:
Hosp Univ Marques Valdecilla, Inst Invest Sanitaria Valdecilla, Cantabria, Spain Queen Mary Univ London, Barts Canc Ctr, London, England

Lee, Jae-Lyun
论文数: 0 引用数: 0
h-index: 0
机构:
Asan Med Ctr, Seoul, South Korea
Univ Ulsan, Coll Med, Seoul, South Korea Queen Mary Univ London, Barts Canc Ctr, London, England

Matsubara, Nobuaki
论文数: 0 引用数: 0
h-index: 0
机构:
Natl Canc Ctr Hosp East, Chiba, Japan Queen Mary Univ London, Barts Canc Ctr, London, England

论文数: 引用数:
h-index:
机构:

Castellano, Daniel
论文数: 0 引用数: 0
h-index: 0
机构:
Hosp Univ 12 Octubre, Madrid, Spain Queen Mary Univ London, Barts Canc Ctr, London, England

Wu, Chunzhang
论文数: 0 引用数: 0
h-index: 0
机构:
Astellas Pharma, Northbrook, IL USA Queen Mary Univ London, Barts Canc Ctr, London, England

Campbell, Mary
论文数: 0 引用数: 0
h-index: 0
机构:
Seagen, Bothell, WA USA Queen Mary Univ London, Barts Canc Ctr, London, England

Matsangou, Maria
论文数: 0 引用数: 0
h-index: 0
机构:
Astellas Pharma, Northbrook, IL USA Queen Mary Univ London, Barts Canc Ctr, London, England

Petrylak, Daniel P.
论文数: 0 引用数: 0
h-index: 0
机构:
Yale Sch Med, Smilow Canc Ctr, New Haven, CT USA Queen Mary Univ London, Barts Canc Ctr, London, England